Introduction of Clinical Question In a normal brain neurons in the substantia nigra produce a

The World Health Organization projects that, by 2040, neurodegenerative diseases will become more common than cancer (Cashell, 2014). Parkinson’s Disease (PD) is widely listed as the second most common neurodegenerative disease (Wuong, 2012; Gillies et al., 2014; Cashell, 2014; Walker, Davidson, & Gray, 2012). This disease, usually characterized by a tremor, but featuring systemic effects, has been diagnosed in one to two percent of people over age 65 (Casey, 2013). Parkinson’s disease is incurable; the goal of the healthcare team is to help the patient to maintain function, independence and quality of life (Miertová et al., 2014; Magennis, Lynch, & Corry, 2014). In the discussion that follows, current understanding of the causes and treatment of PD will be summarized, along with examples of nursing interventions.

Parkinson’s disease is a very well-known disease. It plagues about five million people worldwide, about a million of those cases are in the United States. A person does not lower their chances of getting Parkinson’s by living in a certain part of the world. It is not more, likely to happen in one location than, another. It has to do with age and genetics (“Demographics of parkinson’s,” 2014). It is a disease of the older generation, around about one percent of people over the age of 60 years old have Parkinson’s disease (Hauser, 2014). As one ages the likelihood of a person developing goes up. About four percent of people over the age of 80 years old develop Parkinson’s disease. The percentage of people who have Parkinson’s that are younger than 40 years old, is less than 10 percent. It is more

The article “Living with Parkinson’s and Looking for Relief”, written by Carla Gantz, was found in RDH magazine as a feature in the February 2013 volume on pages 34,36,38, and 95. It is about a dental hygienist, Carla Gantz, who develops Parkinson’s disease while still in practice, and the various ways she copes with the disease. Gantz had Parkinson’s disease that was only on her right side, hand, arm, and shoulder, classifying her as stage 1 Parkinson’s disease. She started off taking low doses of levodopa to help with her tremors, but as the disease progressed, the medications changed, and the doses increased. Her role as a dental hygienist was also affected as her disease progressed. She couldn’t administer local anesthesia, her manual dexterity with instruments became more difficult, and when polishing or scaling, her hand would come to a halt, a secondary motor symptom of Parkinson’s disease. She should break this “freeze” by allowing her left arm to lift up her right arm, but that only worked for so long. Five years after being diagnosed, Gantz had to give up her career because her tremors got worse and her medication increased; she was taking up to thirteen pills per day.

Many may not know Parkinson’s disease is the second most common neurodegenerative disorder in the world. This disease is most seen in the elderly starting at 62 years of age although, younger individuals can still have the disease it isn’t common. Parkinson’s make it difficult for its victims to carry out everyday activities that might have once been easy for them. As the disease progresses it makes it hard for the patient to do things like walk, stand, swallow and speak. A great deal of people don’t realize how helpful therapy can be when dealing with such disease!

When people hear the words Parkinson’s disease they think, “Isn’t that what Michael J. Fox has?” For those who are asking, “Who is Michael J. Fox?” He was the character Marty McFly in the “Back to the Future” movie and played on many TV shows. After being diagnosed with Parkinson’s disease, he set up an organization to research Parkinsonism. What the Michael J. Fox Foundation found was that 40 percent of the people living with Parkinson’s disease experience dystonia as an early symptom or a complication of treatment. This is the only blurb you see on the website about dystonia. In fact, it is so much like the other disorders out there that many people have never heard of it. The purpose of this paper is to inform

Parkinson’s disease, a type of dementia also known as idiopathic or primary parkinsonism, paralysis agitans, or hypokinetic rigid syndrome/HRS, is on the rise in the U.S. Each year there are over 60,000 new cases in the U.S. alone. With the average person diagnosed with Parkinson’s disease over the age of 65 and America’s rapidly growing elderly population, awareness and concern are becoming significant points of interest for many healthcare professionals.

The National Parkinson Foundation located on the website www.parkinson.org, was designed to help people who are affected by parkinson’s disease and to be more aware of the disease through education, treatment options and expert care research. The mission of the non-profit organization states “We make life better for people with Parkinson 's through expert care and research. Everything we do helps people actively enjoy life with their friends, families, children and grandchildren until there is a tomorrow without Parkinson 's” (National Parkinson Foundation). The National Parkinson Foundation targeted audiences includes people who suffer from

Parkinson’s and Alzheimer’s disease are two degenerative brain diseases that differ in their symptoms, causes, treatment, physical and biological indicators. Per Hooley et al. (2017), Parkinson’ disease is thought to be caused by an extended reduction of dopamine, which the absence of constrains normal neural impulses in the brain. After some time, movements such as tremors, stammered speech, diminished or unintentional body movements are demonstrated. Those that suffer from Parkinson’s disease often have an incapability to swallow and muscle stiffness that affects muscles in their faces with mental deterioration occurring as the disease progresses. Parkinson’s disease can be traced to gender and genetics and most of those affected are men that have a family history of the disease (APA, 2013). Treatment for Parkinson’s disease encompasses dopamine precursors to increase the presence of dopamine.

The treatment group received open brain surgery where they were implanted with fetal tissues. The fetal tissues were expected the fetal tissues to slow the progression of Parkinson’s disease enough that patients could take less medication for the disease. Then the placebo group received open brain surgery; however, nothing was changed or implanted. After the surgeries, researchers observed the patients for any form of improvement. Many patients with the implant were able to slowly reduce medication intake. For many patients in the treatment group the ability to move their limbs was less painful and restricted. However, this trail had its setbacks. A select few patients in the placebo group reported with increase function of their limbs. The patients believed it was due to the surgery, when in reality they did not truly receive any surgery to improve their conditions. Due to this information using fetal tissue as a cure for Parkinson’s disease was decided to be further studied before providing it to society as cure for Parkinson’s disease.

Affecting an estimated 4 million people worldwide (NIH), Parkinson’s is one of the less common nervous system disorders. Despite its rarity, Parkinson’s is largely researched because there is no cure and few effective treatments. It also has a big impact on quality of life for those afflicted. This disease usually shows up after age 40 and occurs when the brain cells that are responsible for motor skills die. Symptoms include tremors, inability to move, and impaired cognitive function, all of which worsen over time. Because this is a condition that affects the brain, if an effective treatment can be established, treatments for other more common conditions such as Alzheimer’s may soon follow. This makes it a critical topic for today’s doctors and scientists.

The main outcome of this Prospective Cohort Study is incidence of dementia in subjects with Parkinson’s disease.

In a concise article, registered pharmacist Thomas Viola presents a description of the effects of Parkinson's Disease on one of his patients. Viola discusses etiology of Parkinson's Disease, progression of the disease, and pharmacological treatment. At the heart of his presentation are specific suggestions for dental professionals working with patients affected by the disease.

When people hear Parkinson’s disease they think, “Isn’t that what Michael J Fox has?” For those who are asking who Michael J Fox is, he was Marty McFly in “Back to the Future” movie and he played on many other TV programs who was diagnosed with Parkinson’s disease at an early age and has set up an organization to research Parkinson’s disease. What the Michael J Fox Foundation found out was that 40 percent of the people living with Parkinson’s disease experience Dystonia as an early symptom or a complication of treatment. This is the only blurb you see on the website about Dystonia. In fact, Dystonia is so much like the other disorders that many people have never heard of it. The purpose of this paper is to inform as many people as possible

Parkinson’s disease is a progressive neurological condition which can affect talking, writing, swallowing, walking and memory.

Parkinson's can make the muscles in the jaw and face weaker, which affects chewing and